Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achaogen Inc (NASDAQ:AKAO)

15.84
Delayed Data
As of Sep 22
 +0.10 / +0.64%
Today’s Change
3.68
Today|||52-Week Range
27.79
+21.66%
Year-to-Date
No recent news for Achaogen Inc.

Today’s Trading

Previous close15.74
Today’s open15.67
Day’s range15.16 - 16.32
Volume619,412
Average volume (3 months)780,865
Market cap$669.0M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-101.34%
Earnings growth (this year)+1.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.29%
P/E ratioNM
Price/Sales7.39
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
RETAReata Pharmaceutical...+0.13+0.41%
AKBAAkebia Therapeutics ...+0.05+0.29%
CYTKCytokinetics Inc+0.10+0.70%
PRTKParatek Pharmaceutic...-0.10-0.40%
Data as of 3:59pm ET, 09/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$41.8M
Annual profit (last year)-$71.2M
Net profit margin-170.51%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Kenneth J. Hillan
President &
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts